Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
4,65 CAD | -.--% | -2,11 % | +17,72 % |
08/04 | HLS Therapeutics Inc. anuncia los resultados de los análisis Reduce-IT relativos a los efectos del VASCEPA | CI |
14/03 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Resumen de negocios
Número de empleados: 91
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 80 | 100,0 % | 85 | 100,0 % | +6,38 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
62,3
%
| 48 | 60,2 % | 53 | 62,3 % | +10,03 % |
United States
29,3
%
| 25 | 31,8 % | 25 | 29,3 % | -2,12 % |
Rest of World
8,4
%
| 6 | 7,9 % | 7 | 8,4 % | +12,78 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 56 | 01/05/23 |
John Hanna
DFI | Director of Finance/CFO | - | 22/06/23 |
Ryan Lennox
CMP | Compliance Officer | 43 | 07/05/18 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/06/14 |
Brian Walsh
PRN | Corporate Officer/Principal | - | 01/06/23 |
Patricia Perry
HRO | Human Resources Officer | 48 | 01/07/19 |
David Spence
AUD | Comptroller/Controller/Auditor | 56 | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
John Welborn
CHM | Chairman | 46 | 18/06/21 |
Laura Brege
BRD | Director/Board Member | 66 | 21/03/19 |
John Hanna
DFI | Director of Finance/CFO | - | 22/06/23 |
Craig Millian
CEO | Chief Executive Officer | 56 | 01/05/23 |
Rodney Hill
BRD | Director/Board Member | 56 | 12/03/18 |
Norma Beauchamp
BRD | Director/Board Member | 62 | 01/01/21 |
Kyle Dempsey
BRD | Director/Board Member | 35 | 29/11/22 |
Christian Roy
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 31 886 247 | 31 730 547 ( 99,51 %) | 0 | 99,51 % |
Información de la empresa
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,72 % | 108 M | |
+14,71 % | 70,59 mil M | |
+1,36 % | 25,06 mil M | |
+7,11 % | 8202 M | |
-20,55 % | 7964,53 M | |
-2,98 % | 7915,96 M | |
+3,91 % | 4709,9 M | |
+17,12 % | 4318,65 M | |
-1,24 % | 4007,29 M | |
-3,44 % | 3818,78 M |
- Bolsa de valores
- Acciones
- Acción HLS
- Empresa HLS Therapeutics Inc.